Bannerbild German Brest Group - Patientinnen

Risk factors

What are the risk factors for breast cancer?

Risk factors are things that increase your personal risk of developing breast cancer.

Significance of risk factors

Women with risk factors have an increased probability of actually contracting breast cancer. Important note: this is all a question of probabilities. Some women display all the risk factors but do not develop the disease.

Risk factors also play a role in the early detection of breast cancer: doctors recommend more frequent mammogram screening for women with an increased risk. Further information about early detection methods can be found under the menu item “Early detection”.

Known risk factors

Although the causes of breast cancer are not yet fully understood, researchers have already identified a series of risk factors. It has not been conclusively determined which factors ultimately trigger breast cancer.

Age
The risk of breast cancer increases with age. Most cases of breast cancer occur in women over 50, owing to the fact that the probability of abnormal cell divisions increases with age.

Early onset of menstruation
Women who entered puberty before the age of 12 have a slightly increased risk of breast cancer. The reason for this is the extended period over which these women produce oestrogen. Researchers believe that this female hormone plays a role in the development of breast cancer.

Late pregnancy or childlessness
Women who were over 30 when they gave birth to their first child or who have never had children have a slightly increased risk of contracting the disease.

Heredity
The predisposition to develop breast cancer is hereditary. Women with a first-degree relative – i.e. a mother or sister – who has already developed breast cancer have an increased risk of contracting the disease themselves. Further information is available under the menu item “Heredity”.

Evidence of abnormal breast cells in a biopsy
If changes in breast tissue have already been discovered in a tissue sample, there is an increased risk of contracting the disease.

If tissue changes are discovered via palpation or a mammogram, a biopsy is performed. This involves removing tissue from the breast and examining it for degenerated breast cells under the microscope. In medical terminology, these degenerated cells are referred to as “atypical breast cells”.


News

  • 15.10.2018 GBG Research at ESMO

    Data of several GBG trials and translational research projects will be presented at the upcoming ESMO 2018 Congress, which will take place from 19 to 23 October in Munich, Germany.

    Mehr ...
  • 11.10.2018 BIG newsletter no 9 is out

    We’re delighted to announce that the BIG newsletter BIG Research in Focus, Issue 9 is out and has been published on BIG’s website.

    Mehr ...
  • 27.09.2018 GBG-Jahrestreffen - Save the Date

    GBG-Jahrestreffen - Save the Date

    Das GBG Jahrestreffen 2019 wird am 14. & 15. März 2019 in Niederrad Frankfurt am Main stattfinden.

    Mehr ...
  • 27.09.2018 Paper of the month: models for pCR

    Paper of the month: models for pCR

    A statistical research study that aimed to develop an empirical model for predicting the magnitude of the treatment effects on survival endpoints based on the treatment effects on pathological complete response (pCR) has been published in the Contemporary Clinical Trials.

    Mehr ...
  • 11.09.2018 BCC-Breast Cancer Conference 2019 in Vienna

    BCC-Breast Cancer Conference 2019 in Vienna

    The 16th St. Gallen International Breast Cancer Conference 2019 in Vienna is less than seven months away.

    Mehr ...

GBG Forschungs GmbH
Martin-Behaim-Str. 12 | 63263 Neu-Isenburg | Fax +49 6102 7480-440

+49 6102 7480-0 | nfGBGd